EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

Satoru Mitsuboshi, Kotaro Hitoshi, Ai Ominato, Teruhisa Kinoshita, Yuka Sugimoto, Ayami Kajiwara-Morita, Motoki Urata, Koji Sato, Toshiyuki Sakamaki

European Journal of Clinical Pharmacology · 2025

DOI: 10.1007/s00228-024-03779-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, 2025. Verfasst von Satoru Mitsuboshi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaetsu Hospital, 1459-1 Higashikanazawa, Akiha-ku, Niigata-shi, Niigata, 956-0814, Japan. ccrtyo34057@gmail.com. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Renal Insufficiency, Chronic, Randomized Controlled Trials as Topic, Urinary Tract Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Niigata University of Pharmacy and Applied Life Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsRenal Insufficiency, ChronicRandomized Controlled Trials as TopicUrinary Tract InfectionsHumansHypovolemiaMusculoskeletal Pain

Stichwörter der Autor:innen

Chronic kidney diseaseHypovolemiaMusculoskeletal painRandomized controlled trialSodium-glucose cotransporter-2 inhibitorsSystematic review and meta-analysisUrinary tract infection

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Kaetsu Hospital, 1459-1 Higashikanazawa, Akiha-ku, Niigata-shi, Niigata, 956-0814, Japan. ccrtyo34057@gmail.com.
  • Faculty of Pharmacy, Kinjo Gakuin University, Aichi, Japan.
  • Department of Pharmacy, Niigata Rosai Hospital, Niigata, Japan.
  • Department of Pharmacy, Kariya Toyota General Hospital, Aichi, Japan.
  • Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Pharmacy, Kouseikai Hospital, Nagasaki, Japan.

Förderung

  • Niigata University of Pharmacy and Applied Life Sciences

Zitieren

APA

Mitsuboshi, S., Hitoshi, K., Ominato, A., Kinoshita, T., Sugimoto, Y., Kajiwara-Morita, A., Urata, M., Sato, K., & Sakamaki, T. (2025). Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03779-2

Vancouver

Mitsuboshi S, Hitoshi K, Ominato A, Kinoshita T, Sugimoto Y, Kajiwara-Morita A, et al. Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology. 2025. doi:10.1007/s00228-024-03779-2

BibTeX
@article{Mitsuboshi2025,
  author = {Mitsuboshi, Satoru and Hitoshi, Kotaro and Ominato, Ai and Kinoshita, Teruhisa and Sugimoto, Yuka and Kajiwara-Morita, Ayami and Urata, Motoki and Sato, Koji and Sakamaki, Toshiyuki},
  title = {Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials},
  journal = {European Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1007/s00228-024-03779-2}
}
Kostenlos starten →